Mary Riwes - Concepedia

Author

Mary Riwes

University of Michigan ORCID

Also Known As

M M Riwes, M Riwes, M. Riwes, Mary M Riwes, Mary M. Riwes, Mary Mansour Riwes, Mary Riwes, Riwes, Mary

Publications

928

Citations

H-Index

Concepts

All Affiliations

University of Michigan Johnson University Michigan Medicine Rutgers, The State University of New Jersey Michigan Center for Translational Pathology

About

Mary Riwes is an author at University of Michigan specializing in medicine, transplantation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	129
2	Immunology	3	3	79
3	Blood Transplantation	2	2	73
4	Health Sciences	1	1	23
5	Cellular Therapies	1	1	23

Mary Riwes

Publications

669

Citations

H-Index

Page 1

	Year	Citations
Microbial metabolite sensor GPR43 controls severity of experimental GVHD Hideaki Fujiwara, Melissa D. Docampo, Mary Riwes, Nature Communications	2018	149
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease John Magenau, Steven C. Goldstein, Dan Peltier, Blood	2018	109
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT Sung Won Choi, Thomas Braun, Israel Henig, Blood	2017	67
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease Holly Miller, Thomas Braun, Terri Stillwell, Biology of Blood and Marrow Transplantation	2016	59
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML Yan Song, John Magenau, Y Li, Bone Marrow Transplantation TransplantationGeneticsGenetic EpidemiologyTransplantation MedicinePathology	2015	50
Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition Tomomi Toubai, Hideaki Fujiwara, Corinne Rossi, Nature Microbiology Host ResponseDysbiosisHost Nlrp6Mucosal ImmunologyPathogenesis	2019	42
Cardiovascular Events After Hematopoietic Stem Cell Transplant Alexi Vasbinder, Christopher W. Hoeger, Tonimarie Catalan, JACC CardioOncology	2023	39
Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation Mary Riwes, Jonathan L. Golob, John Magenau, Nature Medicine	2023	33
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma Anita D’Souza, Parameswaran Hari, Marcelo C. Pasquini, Biology of Blood and Marrow Transplantation	2019	29
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation John Magenau, Daniel Peltier, Mary Riwes, Blood Advances Cell TherapyMixed-phenotype Acute LeukemiaImmunologyImmunotherapeuticsImmunotherapy	2021	23

Page 1